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Edited by Robert BaroukiAbstract Here we show that the cell-surface expression of the
alpha subunit of H+-ATP synthase is markedly increased during
adipocyte diﬀerentiation. Treatment of diﬀerentiated adipocytes
with small molecule inhibitors of H+-ATP synthase or antibodies
against alpha and beta subunits of H+-ATP synthase leads to a
decrease in cytosolic lipid droplet accumulation. Apolipoprotein
A-I, which has been shown to bind to the ectopic b-chain of
H+-ATP synthase and inhibit the activity of cell-surface
H+-ATP synthase, also was found to inhibit cytosolic lipid accu-
mulation. These results suggest that the cell-surface H+-ATP
synthase has a previously unsuspected role in lipid metabolism
in adipocytes.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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H+-ATP synthase has been found in all energy-transducing
membranes, including those of mitochondria and chloroplasts.
Several reports, however, have shown that some of its subunits
localize in the plasma membrane of neoplastic, endothelial,
and hepatic cells [1–3]. These ﬁndings suggest that the cell-sur-
face H+-ATP synthase contributes to the regulation of signal
transduction. Surprisingly, it has been proposed that the en-
zyme may be a receptor for ligands such as angiostatin and
apolipoprotein A-1 in endothelial and hepatic cells, respec-
tively [2,3]. Along the same lines, Moser et al. and we have
shown that cell-surface H+-ATP synthase is active in ATP
synthesis. In addition, we have shown that small molecular
substances targeting the F1 subunit complex of H
+-ATP syn-
thase such as resveratrol and piceatannol inhibit proliferation,
migration, and tube formation in Matrigel of human umbilical
vein endothelial cells, suggesting that the activity of H+-ATP
synthase in the plasma membrane contributes to regulation
of signal transduction [4,5].
In addition, it has been shown that a and b subunits of H+-
ATP synthase localize in the plasma membrane of 3T3-L1 pre-
adipocytes and that the expression of the cell-surface H+-ATP
synthase complex is markedly increased during adipogenesis*Corresponding author. Fax: +81 88 633 9550.
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doi:10.1016/j.febslet.2007.06.041[6]. However, the physiological role of cell-surface H+-ATP
synthase remains unknown. Here we show that H+-ATP syn-
thase inhibitors, including resveratrol and piceatannol, inhibit
the induction of terminal diﬀerentiation markers such as lipid
accumulation in adipocytes. In addition, we show that anti-
bodies against a and b subunits of H+-ATP synthase, and apo-
lipoprotein A-I, which has been shown to bind to the ectopic
b-chain of H+-ATP synthase and to inhibit the ATPase activity
of cell-surface H+-ATP synthase, also inhibited the cytosolic li-
pid droplet accumulation in adipocytes. To out knowledge,
this study is the ﬁrst to show the role of cell-surface H+-ATP
synthase in lipid metabolism in adipocytes. The present results
show that cell-surface H+-ATP synthase might be a potential
target for anti-obesity drugs.2. Materials and methods
2.1. Cell culture
Mouse 3T3-L1 preadipocytes were maintained in a Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) (Invitrogen, Carlsbad, CA) with 10%
(v/v) fetal calf serum (FCS) and antibiotics in a humidiﬁed atmosphere
of 95% air and 5% CO2 at 37 C. Diﬀerentiation was induced by incu-
bating the preadipocytes in adipogenic medium (2 lM insulin, 1 lM
dexamethasone, and 250 lM isobutylmethylxanthine in DMEM)
(day 0) for 2 days, followed by changing the medium (every 2 days)
containing 2 lM insulin for another 16 days.
2.2. Evaluation of cytosolic lipid droplet accumulation
3T3-L1 preadipocytes were cultured on 24-well plates (Asahi Tech-
noglass Co., Tokyo) in 0.4 ml of DMEM supplemented with 10%
FCS at 37 C and diﬀerentiated as described above. Diﬀerentiated
3T3-L1 adipocytes (day 16) were incubated with or without 0.1%
dimethylsulfoxide (DMSO) solvent vehicle (control) and the indicated
concentrations of H+-ATP synthase inhibitors for 48 h, and the cells
were then observed under phase-contrast microscopy (magniﬁcation,
400·) (OLYMPUS IX70, OLYMPUS, Tokyo, Japan). To estimate li-
pid accumulation in adipocytes, cells were subjected to Oil Red O
staining as follows. The cells incubated were ﬁxed with 3.7% formalin
in Mg2+- and Ca2+-free phosphate-buﬀered saline (PBS()), washed
once with 60% isopropanol, and then stained with Oil Red O (stock
solution: 5 mg/ml dissolved in 60% triethyl-phosphate; working solu-
tion; 60:40 Oil Red O stock: distilled water) for 1 h at 37 C. The
stained cells were washed once with xylene rapidly, and extracted with
0.6 ml of 99.5% ethanol. The extracts were diluted ten times with
99.5% ethanol, and the absorbance of the diluted extracts was mea-
sured spectrophotometrically at 490 nm.
2.3. Immunostaining of the cell-surface H+-ATP synthase a subunit
3T3-L1 preadipocytes were cultured on 35-mm glass-bottom dishes
(MatTek Corp., Ashland, MA) in 2 ml of DMEM supplemented with
10% FCS at 37 C and diﬀerentiated as described above. The cells were
ﬁxed with 3.7% formalin in PBS for 10 min at room temperature (RT)
and blocked with 2% bovine serum albumin (BSA) overnight at 4 C.blished by Elsevier B.V. All rights reserved.
Fig. 1. Expression of the cell-surface a subunit of H+-ATP synthase
during adipocyte diﬀerentiation. Diﬀerentiation of 3T3-L1 preadipo-
cytes was induced by incubating them in adipogenic medium as
described in Section 2. At days 0, 2, 4, 6, 8, and 10, the expression of
the cell-surface a subunit of H+-ATP synthase was determined by a
ﬂow cytometer as described in Section 2 (A). Note that expression of
the cell-surface a subunit of H+-ATP synthase increased within 2 days
of induction of diﬀerentiation. Adipocytes showing approximately 60%
3406 N. Arakaki et al. / FEBS Letters 581 (2007) 3405–3409The cells were incubated with 1 lg/ml anti-bovine mitochondrial ATP
synthase a subunit mouse monoclonal antibody (Molecular Probes,
Eugene, OR) for 1 h at RT, and washed 4 times with 0.05% Tween–
PBS(). The cells were then incubated with 1 lg/ml Cy3-goat anti-
mouse IgG (H + L) conjugate (ZYMED, San Francisco, CA) for 1 h
at RT, and the cells were then analyzed under a ﬂuorescent microscope
(OLYMPUS IX70, OLYMPUS, Tokyo, Japan) with a color-chilled
CCD camera (CoolSNAP Fx10L, Tokyo, Japan).
2.4. Flow-cytometric analysis of cell-surface H+-ATP synthase a subunit
Diﬀerentiation of 3T3-L1 preadipocytes was induced by incubating
them in adipogenic medium, as described above. At days 0, 2, 4, 6,
8, and 10, the cells were harvested, washed with PBS, blocked with
0.1% BSA, and incubated with 1 lg/ml anti-bovine mitochondrial
ATP synthase a subunit mouse monoclonal antibody for 30 min at
4 C. The cells were incubated with 1 lg/ml Cy3-goat anti-mouse
IgG (H + L) conjugate for 30 min at 4 C, and the cells were then ana-
lyzed by a Coulter EPICS XL-MCL ﬂow cytometer (Coulter Corp.,
Hialeah, FL), as described previously [7].
2.5. Apoptosis assay
Diﬀerentiated 3T3 adipocytes (day 16) were incubated with the indi-
cated concentrations of H+-ATP synthase inhibitors for 48 h at 37 C,
and the apoptotic cells were then detected using an Annexin V-FITC
Apoptosis Detection Kit (BioVision Inc., Mountain View, CA) essen-
tially as described previously [8]. The percentage of apoptotic cells (an-
nexin V positive and propidium iodide negative cells) was determined
by a ﬂow cytometer.
2.6. Statistical analysis
Experimental and control samples used in the functional assays were
compared for statistical signiﬁcance by using Student’s t-test. P < 0.05
was considered as signiﬁcant.diﬀerentiation eﬃciency were immunostained with anti-H+-ATP syn-
thase a antibodies, followed by Cy3-goat anti-mouse IgG (H + L)
conjugate as described in Section 2. (B) Cytosolic lipid droplets
(triacylglycerol:TG) were visualized under a phase-contrast micro-
scope (a), and the cell-surface a subunit was visualized under a
ﬂuorescent microscope (b). Note that the diﬀerentiated cells accumu-
lating cytosolic lipid droplets (arrows) were strongly stained with the
antibody, while the non-diﬀerentiated cells without cytosolic lipid
droplets (arrow heads) were slightly stained with the antibody.3. Results and discussion
3.1. Expression of cell-surface a subunit of H+-ATP synthase
during adipocyte diﬀerentiation
3T3-L1 preadipocyte is one of the most well-characterized
and reliable models for studying adipogenesis. On reaching
conﬂuence, treatment with adipogenic agents induces a pro-
gram of diﬀerentiation manifested by large lipid droplet accu-
mulation as shown in Figs. 1B, 2A, and 3A. When 3T3 L1
preadipocytes were diﬀerentiated into adipocytes, cell-surface
expression of the a subunit of H+-ATP synthase evaluated
by ﬂow cytometric analysis was markedly increased during
adipocyte diﬀerentiation. The increase in the cell-surface a sub-
unit was observed within 2 days after induction of diﬀerentia-
tion (Fig. 1A). The increased expression of the cell-surface a
subunit in diﬀerentiated adipocytes was also conﬁrmed by
immunohistochemical analysis (Fig. 1B). The diﬀerentiated
adipocytes accumulating cytosolic lipid droplets (arrows) were
strongly stained with the antibody against the a subunit of
H+-ATP synthase, while the non-diﬀerentiated cells without
cytosolic lipid droplets (arrow heads) were slightly stained with
the antibody, supporting that the cell-surface H+-ATP syn-
thase might have a speciﬁc function in adipogenesis.
3.2. Eﬀects of H+-ATP synthase inhibitors on lipid droplet
accumulation
As shown in Fig. 2, treatment of the diﬀerentiated 3T3-L1
adipocytes with substances targeting the F1 subunit of H
+-
ATP synthase such as resveratrol and piceatannol led to a
decrease in lipid droplet accumulation (Fig. 2A). Recently, sev-
eral groups of polyphenolic phytochemicals such as apigenin,
kaempferol, daidzein, genistein, quercetin, and epigallocate-chin gallate (EGCG) have been shown to inhibit puriﬁed H+-
ATP synthase [9]. We therefore investigated the eﬀects of these
phytochemicals on lipid droplet accumulation in adipocytes.
As shown in Fig. 2B, these phytochemicals at concentrations
of the previously reported IC50 of the phytochemicals for puri-
ﬁed H+-ATP synthase [9] also inhibited cytosolic lipid droplet
accumulation in the cells by 60–80%, except for EGCG. In
contrast, phytochemicals with no H+-ATP synthase inhibitory
activity such as epigallocatechin (EGC), genistin, and querci-
trin had little eﬀect on cytosolic lipid droplet accumulation
in the cells.
Although EGCG has been shown to have anti-obesity eﬀects
[10–13], it could not reduce the cytosolic lipid droplet accumu-
lation in diﬀerentiated 3T3-L1 adipocytes under our assay con-
ditions. Although the reason for this is unclear, the gallate-ester
moieties of EGCG have been shown to dramatically aﬀect the
physical properties of both the phosphatidylcholine and phos-
phatidyletanolamine bilayers [14]. Thus it is possible that
EGCG has unexpected side eﬀects on various cellular func-
tions, including lipid metabolism, that probably depend on
assay conditions.
Some of the phytochemicals, including resveratrol and gen-
istein, have been reported to induce apoptosis in a variety
of cancer cell lines [15–17], but none of these phytochemicals
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Fig. 2. Treatment of diﬀerentiated 3T3-L1 adipocytes with H+-ATP
synthase inhibitors leads to a decrease in cytosolic lipid droplet
accumulation. (A) Diﬀerentiated adipocytes were incubated with or
without 20 lM resveratrol or 10 lM piceatannol for 48 h. Cytosolic
lipid droplets were visualized under a phase-contrast microscope. The
arrows show lipid droplets. The data shown are representative of three
independent experiments that gave similar results. (B) Diﬀerentiated
adipocytes were incubated with or without H+-ATP synthase inhib-
itors for 48 h, and the levels of intracellular triacylglycerol (TG) were
then determined as described in Section 2. 1; 0.1% DMSO control. 2;
resveratrol (50 lM), 3; piceatannol (10 lM), 4; apigenin (55 lM), 5;
kaempferol (60 lM), 6; daidzein (130 lM), 7; genistein (60 lM), 8;
quercetin (50 lM), 9; curcumin (4 lM), 10; phloretin (70 lM), 11;
EGCG (20 lM), 12; ECG (20 lM), 13; quercitrin (20 lM), 14; genistin
(50 lM). The results shown are the means ± S.E.M. of three indepen-
dent experiments. *signiﬁcantly diﬀerent compared to 0.1% DMSO
control, P < 0.01.
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Fig. 3. Treatment of diﬀerentiated 3T3-L1 adipocytes with anti-H+-
ATP synthase a antibodies (anti-aAb) leads to a decrease in TG
accumulation. Diﬀerentiated 3T3-L1 adipocytes were treated with or
without the indicated concentrations of anti-aAb for 48 h and then the
TG accumulation was observed under a phase-contrast microscopy.
Note that the TG accumulation was inhibited by treatment of anti-
aAb (A-c and B). Arrows show lipid droplets. The data shown are
representative of 3–4 independent experiments that gave similar
results. *signiﬁcantly diﬀerent compared to mock IgG (mIgG),
P < 0.01.
Table 1
Annexin V-positive cells in adipocytes treated with H+-ATP synthase
inhibitors
Treatment Apoptotic cells (%)
DMSO (0.1%) 10.5 ± 0.5
Piceatannol (10 lM) 9.5 ± 2.2
Resveratrol (50 lM) 10.8 ± 0.8
Kaempferol (60 lM) 10.2 ± 1.2
Daidzein (130 lM) 9.8 ± 2.5
Genistein (60 lM) 5.2 ± 2.6
Diﬀerentiated 3T3 adipocytes (day 16) were incubated with the indi-
cated concentrations of H+-ATP synthase inhibitors for 48 h at 37 C,
and apoptotic cells were then detected using an Annexin V-FITC
Apoptosis Detection Kit as described in Section 2.
N. Arakaki et al. / FEBS Letters 581 (2007) 3405–3409 3407signiﬁcantly induced apoptosis in 3T3-L1 preadipocytes at the
concentrations used under our assay conditions (Table 1). In
addition, the phytochemicals used in this study had no eﬀect
on the proliferation of adipocyte under the assay condition
(data not shown), suggesting that the eﬀect of these phyto-
chemicals on cytosolic lipid accumulation was not due to the
cytotoxic activity.
3.3. Eﬀects of the antibodies against a and b subunits of H+-
ATP synthase on lipid droplet accumulation
To support the specialized function of cell-surface H+-ATP
synthase, we next examined the eﬀects of the antibodies against
a and b subunits of H+-ATP synthase on lipid droplet accumu-
lation. As shown in Fig. 3, treatment of the diﬀerentiated
3T3-L1 adipocytes with the anti-H+-ATP synthase a subunit
antibody led to a decrease in lipid droplets, indicating that
the anti-H+-ATP synthase a subunit antibody could mimicthe inhibitory eﬀects of H+-ATP synthase inhibitors. As well
as the anti-H+-ATP synthase a subunit antibody, the anti-
H+-ATP synthase b antibodies (anti-bAb) signiﬁcantly inhib-
ited the cytosolic lipid droplet accumulation (Fig. 4).
3.4. Eﬀect of apolipoprotein A-I on lipid droplet accumulation
It has been proposed that the ectopic b-chain of H+-ATP
synthase is an apolipoprotein A-I (apo A-1) receptor in hepatic
high-density lipoprotein (HDL) endocytosis, and that the
membrane-bound H+-ATP synthase activity is regulated by a









































Fig. 4. Eﬀects of apo A-1 and anti-H+-ATP synthase b antibodies (anti-bAb) on the TG accumulation. Diﬀerentiated 3T3-L1 adipocytes were
treated with or without the indicated concentrations of apo A-1 or anti-bAb for 48 h and the TG levels were determined as described in Section 2.
Pre: preadipocytes. *signiﬁcantly diﬀerent compared to vehicle control or mock IgG, P < 0.01.
3408 N. Arakaki et al. / FEBS Letters 581 (2007) 3405–3409principal plasma apolipoprotein [3]. These ﬁndings allow us to
examine the eﬀects of apo A-I on lipid metabolism in adipo-
cytes. The diﬀerentiated 3T3-L1 adipocytes were treated with
apo A-1 for 48 h, and the cytosolic lipid content was deter-
mined as described above. As shown in Fig. 4, apo A-1 at
concentrations of 1 nM and 10 nM, inhibited cytosolic lipid
droplet accumulation in the cells by 55-60%. We also found
that H+-ATP synthase inhibitors and apolipoprotein A-1 stim-
ulated glycerol release (indicative of lipolysis) from 3T3-L1
adipocytes, while these substances inhibited glycerol-3-phos-
phate dehydrogenase activity which is a terminal diﬀerentia-
tion marker of adipocytes (data not shown).
Recently, it has been reported that ceramide-induced choles-
terol depletion decreases the H+-ATP synthase b content in li-
pid rafts of Schwann cells [19] and that cholesterol loading
increases the translocation of H+-ATP synthase b into mem-
brane caveolae in vascular endothelial cells [18]. These results
also suggest that the ectopic localization of H+-ATP synthase b
plays a role in regulating cellular functions such as cholesterol
homeostasis and lipid metabolism. Although future studies
exploring the signal transduction pathway connecting cell-sur-
face H+-ATP synthase to lipid metabolism are needed to eluci-
date the mechanisms of how H+-ATP synthase inhibitors
inhibit lipid droplet accumulation, the current results indicate
that cell-surface H+-ATP synthase could be a potential target
for the development of anti-obesity drugs.
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